These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20530784)

  • 1. Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications.
    Hirsch IB; Brownlee M
    JAMA; 2010 Jun; 303(22):2291-2. PubMed ID: 20530784
    [No Abstract]   [Full Text] [Related]  

  • 2. Kallistatin as a marker of microvascular complications in children and adolescents with type 1 diabetes mellitus: Relation to carotid intima media thickness.
    El-Asrar MA; Andrawes NG; Ismail EA; Salem SM
    Vasc Med; 2015 Dec; 20(6):509-17. PubMed ID: 26091968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on: Lachin et al. (2007) The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the diabetes control and complications trial: Diabetes 56:1913-1921, 2007.
    Chalew S; Hempe J; McCarter R
    Diabetes; 2008 Feb; 57(2):e4; author reply e5. PubMed ID: 18227521
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemoglobin A1c in diabetes: panacea or pointless?
    Sacks DB
    Diabetes; 2013 Jan; 62(1):41-3. PubMed ID: 23258914
    [No Abstract]   [Full Text] [Related]  

  • 5. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
    Wadén J; Forsblom C; Thorn LM; Gordin D; Saraheimo M; Groop PH;
    Diabetes; 2009 Nov; 58(11):2649-55. PubMed ID: 19651819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile-onset diabetes mellitus. Glucose control and microvascular changes.
    Mueller SM; Latimer DM; Mick MJ
    Indiana Med; 1986 Feb; 79(2):159-64. PubMed ID: 3950377
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes.
    Kong AP; Yang X; Ko GT; So WY; Chan WB; Ma RC; Ng VW; Chow CC; Cockram CS; Tong PC; Wong V; Chan JC
    Diabetes Care; 2007 Apr; 30(4):953-9. PubMed ID: 17259475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
    Bashir M; Elhadd T; Dabbous Z; Gul W; Salameh O; Siddiqui M; Al-Muhannadi H; Petropoulos I; Khan A; Ponirakis G; Malik RA
    Diabetes Metab Syndr; 2021; 15(5):102241. PubMed ID: 34390975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular Complications Associated With Rapid Improvements in Glycemic Control in Diabetes.
    Gibbons CH; Goebel-Fabbri A
    Curr Diab Rep; 2017 Jul; 17(7):48. PubMed ID: 28526993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The level of glycosylated hemoglobin A1c in the erythrocytes of patients with diabetic angio- and polyneuropathies].
    Karabun PM
    Probl Endokrinol (Mosk); 1989; 35(5):33-7. PubMed ID: 2587522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A1c and mortality: an unexpected relationship in patients with advanced heart failure.
    Tayek JA
    Am Heart J; 2006 Jul; 152(1):e5; author reply e7. PubMed ID: 16824822
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes.
    Turk HM; Buyukberber S; Sevinc A; Ak G; Ates M; Sari R; Savli H; Cigli A
    Diabetes Care; 2000 Jun; 23(6):864-7. PubMed ID: 10841017
    [No Abstract]   [Full Text] [Related]  

  • 13. Markers of microvascular complications in insulin dependent diabetes.
    Schultz CJ; Amin R; Dunger DB
    Arch Dis Child; 2002 Jul; 87(1):10-2. PubMed ID: 12089111
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood glucose control and microvascular complications--what do we do now?
    Dahl-Jørgensen K; Brinchmann-Hansen O; Bangstad HJ; Hanssen KF
    Diabetologia; 1994 Dec; 37(12):1172-7. PubMed ID: 7895945
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension.
    Taniguchi A; Fukushima M; Sakai M; Nagata I; Nagasaka S; Doi K; Kinoshita H; Kanda N; Tokuyama K; Nakai Y
    Diabetes Care; 2000 Jun; 23(6):856-7. PubMed ID: 10841009
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diabetic patients with heart disease. Especially strict blood values are important here].
    Standl E
    MMW Fortschr Med; 2006 Oct; 148(41):11. PubMed ID: 17190249
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular disease (CVD) limbo: how soon and low should we go to prevent CVD in diabetes?
    Maahs DM
    Diabetes Technol Ther; 2012 Jun; 14(6):449-52. PubMed ID: 22472062
    [No Abstract]   [Full Text] [Related]  

  • 18. ADVANCE and glycaemia thresholds: a need to clarify the statistical approach.
    Currie CJ
    Diabetologia; 2012 Aug; 55(8):2298-9; author reply 2300. PubMed ID: 22610398
    [No Abstract]   [Full Text] [Related]  

  • 19. Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control.
    Larsen J; Brekke M; Sandvik L; Arnesen H; Hanssen KF; Dahl-Jorgensen K
    Diabetes; 2002 Aug; 51(8):2637-41. PubMed ID: 12145181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD40L in children and adolescents with type 1 diabetes: relation to microvascular complications and glycemic control.
    El-Asrar MA; Adly AA; Ismail EA
    Pediatr Diabetes; 2012 Dec; 13(8):616-24. PubMed ID: 22702645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.